In this regard, our study provides further evidence that patients with elevated LA pressure due to MS and preserved LVEF have elevated MR-proANP levels, which decline after successful PMC, without any significant relation with the variation in pulmonary arterial pressure. The gene discussed is NPPA; the disease is myeloid sarcoma.